These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6202980)

  • 1. Cardiovascular profile of Ro 13-6438, a novel positive inotropic agent with vasodilating properties.
    Eigenmann R; Gerold M; Holck M
    J Cardiovasc Pharmacol; 1984; 6(3):511-9. PubMed ID: 6202980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the mechanism of positive inotropic activity of Ro 13-6438, a structurally novel cardiotonic agent with vasodilating properties.
    Holck M; Thorens S; Muggli R; Eigenmann R
    J Cardiovasc Pharmacol; 1984; 6(3):520-30. PubMed ID: 6202981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of RG W-2938: a cardiotonic agent with vasodilator activity.
    Barrett JA; Woltmann RF; Swillo RS; Kasiewski C; Faith WC; Campbell HF; Perrone MH
    J Cardiovasc Pharmacol; 1990 Oct; 16(4):537-45. PubMed ID: 1706794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic effects of Ro 13-6438, a new inotropic agent with vasodilating properties.
    Braun S; Shargorodsky B; Talit U; Laniado S
    Drugs Exp Clin Res; 1986; 12(5):381-4. PubMed ID: 3720522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs.
    Pagel PS; Harkin CP; Hettrick DA; Warltier DC
    Anesthesiology; 1994 Oct; 81(4):974-87. PubMed ID: 7943849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular pharmacology of the vasodilator-cardiotonic agent, 349U85.
    Steffen RP; Wastila WB
    J Cardiovasc Pharmacol; 1992 Oct; 20(4):579-89. PubMed ID: 1280714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic profile of BM 14.478: a new positive inotropic and vasodilating agent.
    Müller-Beckmann B; Sponer G; Strein K; Bartsch W
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):1-7. PubMed ID: 2450246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular effects of NSP-804 and NSP-805, novel cardiotonic agents with vasodilator properties.
    Mochizuki N; Uchida S; Miyata H
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):983-95. PubMed ID: 7687727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 2nd communication: studies in dogs.
    Ohhara H; Ogawa T; Takeda M; Katoh H; Daiku Y; Igarashi T
    Arzneimittelforschung; 1989 Jan; 39(1):38-45. PubMed ID: 2719742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amrinone enhances myocardial contractility and improves left ventricular diastolic function in conscious and anesthetized chronically instrumented dogs.
    Pagel PS; Hettrick DA; Warltier DC
    Anesthesiology; 1993 Oct; 79(4):753-65. PubMed ID: 8214755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inotropic and chronotropic activity of a new cardiotonic agent, DM 9278 (1,2,3,4,8,9,10,12-octahydro[2,1-b]pyrido[2,3-f]quinazolin-9-one ), on isolated dog atrial and ventricular muscles.
    Chiba S; Furukawa Y; Saegusa K; Ogiwara Y
    Jpn Heart J; 1986 May; 27(3):387-94. PubMed ID: 3761569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac and hemodynamic profile of the new cardiotonic agent, DPI 201-106, in the conscious dog.
    Gerard JL; Berdeaux A; Giudicelli JF
    Eur J Pharmacol; 1989 Jun; 165(1):39-49. PubMed ID: 2767134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cardiovascular pharmacology of ICI 170777 ((6RS)-6-methyl-5-(pyrid-4-yl)-3H,6H-1,3,4- thiadiazin-2-one) a novel compound with positive inotropic and vasodilator effects.
    Collis MG; Keddie JR; Rouse W
    Br J Pharmacol; 1989 Jun; 97(2):409-18. PubMed ID: 2758224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the inotropic and arrhythmogenic action of the sodium channel activator BDF 9148: a comparison to its S-enantiomer BDF 9196, to its congener DPI 201-106, to norepinephrine, and to ouabain.
    Baumgart D; Ehring T; Krajcar M; Skyschally A; Heusch G
    Basic Res Cardiol; 1994; 89(1):61-79. PubMed ID: 8010937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of LY175326: a potent cardiotonic agent with vasodilator activities.
    Hayes JS; Pollock GD; Wilson H; Bowling N; Robertson DW
    J Pharmacol Exp Ther; 1985 May; 233(2):318-26. PubMed ID: 3999023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the cardiovascular activities of a new cardiotonic agent, MDL 17043 (1,3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazole-2-one).
    Roebel LE; Dage RC; Cheng HC; Woodward JK
    J Cardiovasc Pharmacol; 1982; 4(5):721-9. PubMed ID: 6182401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of inotropic agents on coronary and systemic hemodynamics of conscious dogs: actions of milrinone, dopamine, ouabain and MCI-154.
    Al-Wathiqui MH; Shimshak TM; Brooks HL; Preuss KC; Wynsen JC; Gross GJ; Warltier DC
    Pharmacology; 1988; 36(4):217-27. PubMed ID: 3380877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive inotropic and hemodynamic properties of flosequinan, a new vasodilator, and a sulfone metabolite.
    Falotico R; Haertlein BJ; Lakas-Weiss CS; Salata JJ; Tobia AJ
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):412-8. PubMed ID: 2476620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic and myocardial energetic effects of CK-3197, a selective positive inotropic agent.
    Greenberg S; Touhey B
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):145-53. PubMed ID: 1708048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.